Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$451.42 - $524.21 $9,028 - $10,484
20 Added 250.0%
28 $12,000
Q2 2023

Nov 27, 2023

SELL
$443.86 - $535.96 $19,529 - $23,582
-44 Reduced 84.62%
8 $3,000
Q1 2023

Nov 27, 2023

BUY
$476.57 - $513.28 $24,781 - $26,690
52 New
52 $25,000
Q1 2022

Aug 16, 2022

SELL
$363.17 - $465.45 $3,631 - $4,654
-10 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$389.15 - $471.22 $3,891 - $4,712
10 New
10 $4,000
Q4 2020

Jan 29, 2021

SELL
$388.23 - $452.01 $1,552 - $1,808
-4 Closed
0 $0
Q3 2020

Oct 09, 2020

SELL
$381.58 - $427.77 $1.87 Million - $2.1 Million
-4,906 Reduced 99.92%
4 $2,000
Q2 2020

Aug 11, 2020

BUY
$291.63 - $410.65 $1.43 Million - $2.01 Million
4,905 Added 98100.0%
4,910 $1.9 Million
Q1 2020

Apr 13, 2020

BUY
$214.43 - $380.2 $1,072 - $1,901
5 New
5 $2,000
Q1 2019

May 14, 2019

SELL
$262.61 - $310.3 $2.02 Million - $2.38 Million
-7,680 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$273.36 - $353.98 $2.1 Million - $2.72 Million
7,680 New
7,680 $2.6 Million

Others Institutions Holding HUM

About HUMANA INC


  • Ticker HUM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 126,554,000
  • Market Cap $30.4B
  • Description
  • Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services t...
More about HUM
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.